J. Martin

Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery.

J. Cotton, A. Mathur, Y. Hong, 2002, European heart journal.

Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor.

S. Ylä-Herttuala, A. Mathur, John F. Martin, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Human monocyte characteristics are altered in hypercholesterolaemia.

P. Bath, A. Gladwin, J. Martin, 1991, Atherosclerosis.

The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes.

S. Collot-Teixeira, J. Mcgregor, L. Mcgregor, 2007, Current pharmaceutical design.

Endothelin and PDGF do not stimulate peripheral blood monocyte chemotaxis, adhesion to endothelium, and superoxide production.

P. Bath, J. Martin, S. A. Mayston, 1990, Experimental cell research.

Learning from vascular remodelling.

J. Martin, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.

J. Erusalimsky, I. Zachary, P. Baskerville, 1995, Circulation.

MAC-1 mediates adherence of human monocytes to endothelium via a protein kinase C dependent mechanism.

A. Gladwin, R. Booth, D. Hassall, 1990, Biochimica et biophysica acta.